See how Dexcom products can help optimise your patients' glucose control and support their quality of life.
Smart devices sold separately†
A leader in diabetes care
Dexcom is dedicated to developing innovative glucose monitoring technology and products to help patients and Healthcare Professionals improve diabetes management.
As the world's first real-time, integrated CGM (rt-iCGM), the Dexcom G6 Continuous Glucose Monitoring (CGM) System offers a range of features and benefits that help make that possible.
1st mobile CGM system
1st CGM system indicated for non-adjunctive use (insulin dosing without fingersticks*)
Redefining the CGM landscape
Dexcom delivered the next generation of CGM technology with the development of Dexcom G6: a zero-fingersticks*, accurate1 and interoperable real-time CGM (rt-CGM) system.
Formatted Block Title
Provides exceptional accuracy1
Provides exceptional accuracy1
DEXCOM G6 PERFORMANCE METRICS1
WITH AN OVERALL MARD OF 9% AND A SUSTAINED ACCURACY OVER TIME,1 THE DEXCOM G6 DEMONSTRATES EXCEPTIONAL ACCURACY.
|
%15/15 (0.8 mmol/L)ǂ |
%20/20 (1.1 mmol/L)§ |
MARD|| | |
|---|---|---|---|
| Overall (Combine study data from paediatrics and adults, see below) | 83.3% | 93.9% | 9.0% |
| Overall accuracy over time | |||
| Day 1 | 81.5% | 92.2% | 9.3% |
| Days 4 - 5 | 85.8% | 95.5% | 9.4% |
| Day 10 | 82.4% | 92.5% | 9.0% |
ACCURACY AT VARIOUS RATES OF CHANGE2
RISING OR FALLING, DEXCOM G6 DEMONSTRATES ACCURACY EVEN WHEN LEVELS RAPIDLY OR SLOWLY RISE OR FALL.2
|
CGM RATE OF CHANGE (mg/(dL · min)) |
%20/20 |
|---|---|
| < -2 | 89.7% |
| [-2, -1) | 93.0% |
| [-1,0) | 93.9% |
| [0.1) | 92.7% |
| (1,2] | 89.6% |
| > 2 | 87.1% |
Supports optimal diabetes management
Zero fingersticks*or scanning required
Smart device compatibility†
Accuracy during critical times3
Supports improved glycaemic outcomes (multiple measures)4-7
Glucose data sharing with loved ones**
Customisable high and low alerts
Interoperability in insulin delivery
Dexcom has integrated its rt-CGM technology through insulin pumps and digital health partnerships to support more customisable and convenient treatment options.
Why CGM
What is CGM?
Learn how continuous glucose monitoring (CGM) is a powerful tool to help improve diabetes management.
Proven Outcomes
Review evidence demonstrating the impact CGM use can have on glycaemic control.
Patient Benefits
Whether a patient with type 1 using injections, Flash or pump, your patients may benefit.
* If your glucose alerts and readings from Dexcom G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
† Compatible smart devices are sold separately. For a list of compatible smart devices, please visit www.dexcom.com/compatibility.
‡ % of CGM readings within ±15 mg/dL of YSI lab reference values ≤ 100mg/dL or ±15% of YSI values > 100mg/dL.
§ Analogous to %15/15 (see previous footnote).
II MARD is a statistical measure of accuracy; the lower the number, the better.
** Internet connectivity required for data sharing. Following requires the use of the Follow App. Followers should always confirm readings on the Dexcom G6 App or Receiver before making treatment decisions.
1 Shah VN, et al. Diabetes Technol Ther. 2018.
2 Wadwa RP, et al. Diabetes Technol Ther. 2018.
3 Dexcom G6 CGM System User Guide, 2018.
4 Beck RW, et al. JAMA. 2017;317(4):371-378.
5 Reddy M, et al. Diabet Med. 2017.
6 Heinemann L, et al. Lancet. 2018.
7 Welsh JB et al. Diabetes Technol Ther 2019;21(3):128-32.